Legal & General Group Plc decreased its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 22.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 372,288 shares of the company's stock after selling 109,539 shares during the quarter. Legal & General Group Plc owned 0.65% of Molina Healthcare worth $108,354,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently made changes to their positions in the company. HighTower Advisors LLC boosted its stake in Molina Healthcare by 2.1% during the 3rd quarter. HighTower Advisors LLC now owns 2,627 shares of the company's stock valued at $906,000 after purchasing an additional 55 shares during the last quarter. Quantinno Capital Management LP lifted its holdings in shares of Molina Healthcare by 29.6% during the third quarter. Quantinno Capital Management LP now owns 5,413 shares of the company's stock valued at $1,865,000 after purchasing an additional 1,235 shares in the last quarter. MML Investors Services LLC boosted its position in shares of Molina Healthcare by 23.2% during the third quarter. MML Investors Services LLC now owns 2,133 shares of the company's stock valued at $735,000 after buying an additional 401 shares during the last quarter. Coldstream Capital Management Inc. increased its holdings in Molina Healthcare by 6.2% in the 3rd quarter. Coldstream Capital Management Inc. now owns 2,298 shares of the company's stock worth $787,000 after buying an additional 135 shares in the last quarter. Finally, Virtu Financial LLC purchased a new position in Molina Healthcare in the 3rd quarter worth about $2,111,000. Hedge funds and other institutional investors own 98.50% of the company's stock.
Insider Transactions at Molina Healthcare
In related news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.26% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on MOH shares. Guggenheim began coverage on shares of Molina Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. UBS Group lowered their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. Finally, Mizuho increased their target price on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $359.42.
Read Our Latest Research Report on Molina Healthcare
Molina Healthcare Stock Performance
MOH traded up $1.65 during midday trading on Wednesday, reaching $337.15. The company had a trading volume of 322,531 shares, compared to its average volume of 738,396. The business has a 50-day moving average of $312.03 and a two-hundred day moving average of $308.21. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $370.99. The company has a market cap of $18.44 billion, a P/E ratio of 16.50, a P/E/G ratio of 1.06 and a beta of 0.70.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, equities research analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
